Zostavax was approved by the Centers for Disease Control and Prevention (CDC) despite a dearth of convincing efficacy tests. The CDC has since recommended that only those 60 and older should take the vaccine. The FDA, by contrast, approved it for people 50 and older. The CDC has also warned that those aged 50 – 59 may lose the alleged protection benefits of the vaccine by the time they reach 60.
People in their 60s are at the greatest risk of getting shingles, which is why the CDC recommends it for that age group. Meanwhile, the vaccine’s labeling does not make clear how long an injection might last (if it works at all, which is an open question). The CDC recommends that people don’t get the shot until they are at least 60, because that’s probably when they are going to need it the most.
Shingles Vaccine Efficacy Questionable
The CDC has stated – with Merck’s encouragement through short-term studies – that the Zostovax vaccine reduces the risk of shingles by a mere 51 percent. That paltry number makes it difficult to discern whether it works at all for anyone. Two unconvincing studies by Merck provide flimsy cover for whether the vaccine works at all or is worth the risk.
Shingles Vaccine Injury Lawyer
Attorney David Matthews, whose law firm is handling shingles cases, said injuries from the Zostavax vaccine are many and varied. Shingles vaccine injuries can vary from a person’s contracting shingles to going blind in one eye, suffering brain damage or paralysis in the extremities, or even dying.
Mr. Matthews said, “Merck failed to warn about Zostavax’ serious side effects and the vaccine doesn’t do what Merck claims it does.” (Related: Shingles vaccine made with pig gelatin, MSG and residual components of human DNA from an aborted fetus. Why?)
Responding to a Natural News story, a Merck spokesperson said, “Nothing is more important to Merck than the safety of our medicines and vaccines.”
If so, then why are thousands of people experiencing ailments associated with the disease the vaccine is supposed to cure? Part of the problem appears to be that the vaccine is made from a live shingles virus. Is Zostavax causing more harm than good? According to Shingles vaccine lawsuits, that is exactly what is happening.
• Zostavax was approved by the FDA in 2006.
• Zostavax pulled in $749 million in sales for Merck in 2016.
• Zostavax is the only approved shingles vaccine in the United States.
Meanwhile, GlaxoSmithKline is working on a second shingles vaccine called Shingrix. GSK is still seeking FDA approval for its new vaccine.
- Shingles Vaccine? Really?
- Shingles Vaccine Lawsuit